Attention-Deficit/Hyperactivity Disorder
Conditions
Interventions
ADHD group:Concerta vs placebo
Control group:None
Sponsors
Peking University Sixth Hospital
Eligibility
Sex/Gender
All
Age
9 Years to 16 Years
Inclusion criteria
Inclusion criteria: ADHD group: 1. Psychiatrists confirmed the diagnosis of ADHD in DSM-IV criteria and no other neurodevelopmental disorders diagnosis, such as autism; 2. Aged 9-16 years old; 3. Did not received drug treatment for ADHD before; 4. Eyesight or corrected eyesight was normal; 5. No nervous system disease or other serious somatic diseases; 6. No history of severe extracranial injuries that led to coma. Control group: 1. Psychiatrists confirmed no mental disorders diagnosis; 2. Aged 9-16 years old; 3. Did not received drug treatment for mental illness before; 4. Eyesight or corrected eyesight was normal; 5. No nervous system disease or other serious somatic diseases; 6. No history of severe extracranial injuries that led to coma.
Exclusion criteria
Exclusion criteria: ADHD group: 1. the co-morbidity was diagnosed by Kiddie-Sads- lifelong version, and the children with severe mental disorders, such as schizophrenia and affective disorder, were excluded (Since opposing defiant disorder was common comorbid disorders, such children with opposing defiant disorder were included); 2. Chinese Wechsler Intelligence Scale for Children (C-WISC) IQ < 80; 3. other nervous system diseases such as epilepsy. Control group: 1. IQ(C-WISC) < 80; 2. other organic diseases of nervous system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Electroencephalogram / Event-related potential; | — |
Secondary
| Measure | Time frame |
|---|---|
| ADHD Rating Scale –IV;Behavior measurement; | — |
Countries
China
Contacts
Public ContactSun Li
Peking University Sixth Hospital
Outcome results
None listed